Yesterday, staples (and food stocks) got obliterated. Perhaps it was the Novo Nordisk ( NVO ) pill for weight loss, perhaps tax selling. I thought it was extreme: https://www.twitter.com/Barchart/status/20036043199169700…
Read in context ›Novo Nordisk Stock (NVO)
Track Novo Nordisk stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
NVO
Novo Nordisk
healthcare
$45.57
▼ -23.56 (-34.59%) past year
Market Cap
$198.44B
P/E Ratio
5.4x
1Y Return
-34.59%
EPS (TTM)
$4.27
Read the latest TheStreet Pro articles mentioning Novo Nordisk, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
57 articlesDaily Diary Mentions
4 mentionsConsumer Staples Take a Hit Novo Nordisk Slips in Premarket Shares of Novo Nordisk ( NVO ) are falling premarket trading trading after the company said its pill version of Ozempic (semaglutide) did not slow the progression of Alzheimer’s disease in two large studies that had aime…
Read in context ›90 Minutes to Go The major indexes continue to grind a bit higher since my last post. It will be interesting to see if we get any significant movement in the last 90 minutes of the trading day. Investors should just get used to the Fed b…
Read in context ›Subscriber Comment of the Day From Mainy: mainframe GLP-1 Thoughts As a holder of NVO for over ten years, I have watched this industry develop. .I call the 2 big players "Penn and Teller". On the one hand you have LLY(Penn) who is promotional--they b…
Read in context ›